are we ready for mrd-guided therapy in multiple myeloma?
Published 2 years ago • 125 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
4:05
are we ready to use minimal residual disease (mrd) to direct multiple myeloma therapy?
-
2:27
mrd-guided therapy in multiple myeloma
-
1:38
using mrd to guide therapy in multiple myeloma
-
0:52
mrd for multiple myeloma: is it ready for prime-time?
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies
-
0:47
sustained mrd for treatment guidance in myeloma
-
1:07
mrd-guided treatment in multiple myeloma
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
1:46
mrd-guided therapy for myeloma
-
1:30
mrd: an important topic in myeloma therapy
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
3:01
the benefit of using mrd to guide treatment decisions in multiple myeloma
-
2:30
the importance of mrd-guided therapy in all
-
1:15
using mrd to guide treatment decisions in myeloma
-
1:20
mrd in myeloma
-
1:33
the rise of mrd in multiple myeloma: could this be an answer to a cure?
-
1:23
next steps in myeloma research: mrd-driven studies, immunotherapy & approaching a cure
-
1:42
mrd: its role and importance for myeloma treatment